24025

544187

KRONOX

img img img img
No Data Available

KRONOX LAB SCIENCES LTD Share Price Update

As of the latest trading session, KRONOX LAB SCIENCES LTD share price is currently at ₹121.5, which is down by ₹-0.86 from its previous closing. Today, the stock has fluctuated between ₹121.10 and ₹123.75. Over the past year, KRONOX LAB SCIENCES LTD has achieved a return of -26.41%. In the last month alone, the return has been -6.95%.

KRONOX LAB SCIENCES LTD performance

Today’s low

Today’s high

₹ 121.10 ₹ 123.75
₹ 121.80

52 week low

52 week high

₹ 118.00 ₹ 207.49
₹ 121.80

Open Price

₹ 123.75

Prev. Close

₹ 122.36

Volume (Shares)

18912.00

Total traded value

₹ 23.03

Upper Circuit

₹ 146.83

Lower Circuit

₹ 97.89

info

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

KRONOX LAB SCIENCES LTD fundamentals


  • Market cap (Cr)

    451.90

  • P/E Ratio (TTM)

    17.58

  • Beta

    1.10

  • Book Value / share

    27.32

  • Return on equity

    32.57%

  • EPS (TTM)

    6.95

  • Dividend yield

    0.41%

  • Net profit/quarter (Cr)

    6.68

info icon alternate text
  • Market cap (Cr)

    451.40

  • P/E Ratio (TTM)

    17.58

  • Beta

    1.11

  • Book Value / share

    27.32

  • Return on equity

    32.57%

  • EPS (TTM)

    6.95

  • Dividend yield

    0.41%

  • Net profit/quarter (Cr)

    6.68

info icon alternate text

KRONOX LAB SCIENCES LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 25.27
Operating Expense 17.81
Net Profit 6.59
Net Profit Margin (%) 26.07
Earnings Per Share (EPS) 1.79
EBITDA 9.15
Effective Tax Rate (%) 23.37
Particulars SEP 2025 (Values in Cr)
Revenue 25.53
Operating Expense 17.40
Net Profit 6.68
Net Profit Margin (%) 26.16
Earnings Per Share (EPS) 1.82
EBITDA 9.69
Effective Tax Rate (%) 27.23
Particulars JUN 2025 (Values in Cr)
Revenue 24.29
Operating Expense 16.72
Net Profit 6.28
Net Profit Margin (%) 25.85
Earnings Per Share (EPS) 1.70
EBITDA 8.84
Effective Tax Rate (%) 25.59
Particulars MAR 2025 (Values in Cr)
Revenue 26.13
Operating Expense 18.73
Net Profit 6.32
Net Profit Margin (%) 24.18
Earnings Per Share (EPS) 1.72
EBITDA 8.66
Effective Tax Rate (%) 24.06
Particulars DEC 2024 (Values in Cr)
Revenue 24.01
Operating Expense 16.00
Net Profit 6.53
Net Profit Margin (%) 27.19
Earnings Per Share (EPS) 1.77
EBITDA 9.19
Effective Tax Rate (%) 26.04
Particulars MAR 2025 (Values in Cr)
Revenue 100.19
Operating Expense 68.45
Net Profit 25.47
Net Profit Margin (%) 25.42
Earnings Per Share (EPS) 6.91
EBITDA 35.65
Effective Tax Rate (%) 25.67
Particulars MAR 2024 (Values in Cr)
Revenue 89.86
Operating Expense 62.83
Net Profit 21.35
Net Profit Margin (%) 23.75
Earnings Per Share (EPS) 5.81
EBITDA 29.90
Effective Tax Rate (%) 25.37
Particulars MAR 2023 (Values in Cr)
Revenue 95.58
Operating Expense 75.45
Net Profit 16.40
Net Profit Margin (%) 17.15
Earnings Per Share (EPS) 4.30
EBITDA 23.63
Effective Tax Rate (%) 25.58
Particulars MAR 2022 (Values in Cr)
Revenue 82.25
Operating Expense 64.99
Net Profit 13.63
Net Profit Margin (%) 16.57
Earnings Per Share (EPS) 565.43
EBITDA 20.80
Effective Tax Rate (%) 25.76
Particulars MAR 2021 (Values in Cr)
Revenue 62.46
Operating Expense 50.01
Net Profit 9.73
Net Profit Margin (%) 15.57
Earnings Per Share (EPS) 403.73
EBITDA 15.58
Effective Tax Rate (%) 26.39
Particulars MAR 2025 (Values in Cr)
Book Value / Share 24.28
ROE % 32.57
ROCE % 43.81
Total Debt to Total Equity 0.00
EBITDA Margin 35.58
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.87
ROE % 38.45
ROCE % 51.29
Total Debt to Total Equity 0.00
EBITDA Margin 33.27
Particulars MAR 2023 (Values in Cr)
Book Value / Share 12.06
ROE % 38.54
ROCE % 49.47
Total Debt to Total Equity 0.04
EBITDA Margin 24.72
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1674.40
ROE % 40.59
ROCE % 50.17
Total Debt to Total Equity 0.10
EBITDA Margin 25.28
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1112.61
ROE % 38.80
ROCE % 50.36
Total Debt to Total Equity 0.07
EBITDA Margin 24.94
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 8.43
Total Assets 98.82
Total Liabilities 98.82
Total Equity 90.10
Share Outstanding 3
Price to Book Ratio 5.92
Return on Assets (%) 25.76
Return on Capital (%) 28.26
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.64
Total Assets 73.99
Total Liabilities 73.99
Total Equity 66.30
Share Outstanding 3
Price to Book Ratio 0.00
Return on Assets (%) 28.85
Return on Capital (%) 32.2
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.56
Total Assets 54.03
Total Liabilities 54.03
Total Equity 44.75
Share Outstanding 3
Price to Book Ratio 0.00
Return on Assets (%) 30.35
Return on Capital (%) 36.65
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.81
Total Assets 56.78
Total Liabilities 56.78
Total Equity 40.35
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 23.99
Return on Capital (%) 33.24
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.05
Total Assets 37.64
Total Liabilities 37.64
Total Equity 26.81
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 25.84
Return on Capital (%) 36.27
Particulars MAR 2025 (Values in Cr)
Net Income 34.27
Cash from Operations 39.57
Cash from Investing -28.39
Cash from Financing -1.85
Net change in Cash 0.44
Free Cash Flow 42.68
Particulars MAR 2024 (Values in Cr)
Net Income 28.60
Cash from Operations 24.76
Cash from Investing -17.31
Cash from Financing 0.00
Net change in Cash 0.10
Free Cash Flow 37.03
Particulars MAR 2023 (Values in Cr)
Net Income 22.04
Cash from Operations 25.38
Cash from Investing -6.59
Cash from Financing -13.39
Net change in Cash -0.32
Free Cash Flow 33.80
Particulars MAR 2022 (Values in Cr)
Net Income 18.35
Cash from Operations 13.81
Cash from Investing -7.59
Cash from Financing -0.66
Net change in Cash 0.75
Free Cash Flow 17.60
Particulars MAR 2021 (Values in Cr)
Net Income 13.22
Cash from Operations 14.87
Cash from Investing -2.95
Cash from Financing -7.09
Net change in Cash 1.26
Free Cash Flow 16.52
Company Name Price P/E P/B Market Cap 52 Week Low/High
ATUL LTD 6617.30 32.78 3.29 19482.49 4882.00 / 7793.00
BASF INDIA LTD 3659.85 42.95 4.18 15841.89 3522.85 / 5418.20
ORIENTAL AROMATICS LIMITED 298.80 0.00 1.51 1005.57 250.35 / 430.00
DEEPAK FERTILISERS & PETROCHEM 1030.85 14.87 1.99 13013.23 888.25 / 1776.95
DEEPAK NITRITE LTD 1648.10 41.47 4.07 22478.94 1512.80 / 2255.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCE PETROCHEMICALS LTD. 143.70 261.27 3.47 12.93 130.20 / 242.00
ATUL LTD 6617.30 37.69 3.35 19482.49 4882.00 / 7793.00
BASF INDIA LTD 3659.85 41.18 4.15 15841.89 3522.85 / 5418.20
ORIENTAL AROMATICS LIMITED 298.80 32.06 1.45 1005.57 250.35 / 430.00

KRONOX LAB SCIENCES LTD shareholding pattern

Holding

23.74%
74.2%
0.04%
2.0%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

KRONOX LAB SCIENCES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
121.80 -0.45 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 125.90
  • 26 Days 128.00
  • 10 Days 126.10
  • 50 Days 132.40
  • 12 Days 126.10
  • 100 Days 140.80
  • 20 Days 127.00
  • 200 Days 149.70
123.45 PIVOT

First Support

120.41

First Resistance

125.41

Second Support

118.45

Second Resistance

128.45

Third Support

115.41

Third Resistance

130.41

RSI

38.89

ADX

31.93

MACD

-1.83

Williams % R

-75.28

Commodity Channel Index (CCI)

-48.10

Date

2026-02-13

Week

20323.00

Same Day

24581.00

Month

23576.00

1 Year

1.11

3 Year

0.96

Over 1 Month

-6.95%

down

Over 1 Year

-26.41%

down

Over 3 Months

-19.27%

down

Over 3 Years

0.00%

down

Over 6 Months

-23.85%

down

Over 5 Years

0.00%

down

KRONOX LAB SCIENCES LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
08 Aug 2025 0.5 Final 08 Aug 2025 Equity shares
23 Aug 2024 0.5 Final 23 Aug 2024 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
08 Aug 2025 0.5 Final 08 Aug 2025 Equity shares
23 Aug 2024 0.5 Final 23 Aug 2024 Equity shares

Top Gainers

KRONOX LAB SCIENCES LTD Share Price

Kronox Lab Sciences Limited was incorporated on November 18, 2008 as 'Kronox Lab Sciences Private Limited', a Private Limited Company, dated November 18, 2008 issued by the Assistant Registrar of Companies, Gujarat. Subsequently, Company converted into a Public Limited Company and a fresh Certificate of Incorporation dated June 11, 2019 was issued by the Registrar of Companies, Ahmedabad, recording the change in name of Company to 'Kronox Lab Sciences Limited'.

The Company began its journey in 2009, by opening the manufacturing of High Purity Speciality Fine Chemicals at Unit I. It expanded Unit I for manufacturing of High Purity Speciality Fine Chemicals used in pharmaceutical and nutraceutical industries in 2011. Further, it started manufacturing High Purity Speciality Fine Chemicals to solar industries. Along with factory shed, it commenced operations at Unit II in 2015 and started manufacturing of products at Unit II in 2019.

The Company manufacture High Purity Speciality Fine and Inorganic Chemicals, Metallic and Phosphate Chemicals for diversified end user industries. Their High Purity Speciality Fine Chemicals are used mainly as (i) reacting agents and raw material in the manufacturing of Active Pharmaceutical Ingredients (APIs); (ii) excipients in pharmaceutical formulations; (iii) reagents for scientific research and laboratory testing; (iv) ingredients in nutraceuticals formulations; (v) process intermediates and fermenting agents in biotech applications; (vi) ingredients in agrochemical formulations; (vii) ingredients in personal care products; (viii) refining agents in metal refineries; and (ix) ingredients in animal health products, amongst others.

On June 6, 2024, Company came up with the initial public offer of issuing 95,70,000 equity shares of Rs 10 each by raising funds of Rs 130.15 crores through offer for sale.

Parent organization Indian Private
NSE symbol KRONOX
Founded 2008
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Kronox Lab Sciences Ltd?

Answer Field

Kronox Lab Sciences Ltd share price is for NSE ₹ 121.50 & for BSE ₹ 121.65 as on Feb 16 2026 03:29 PM.

What is the Market Cap of Kronox Lab Sciences Ltd Share?

Answer Field

The market cap of Kronox Lab Sciences Ltd for NSE ₹ 451.90 & for BSE ₹ 0.00 as on Feb 16 2026 03:29 PM.

What is the 52 Week High and Low of Kronox Lab Sciences Ltd?

Answer Field

The 52 Week High and Low of Kronox Lab Sciences Ltd for NSE is ₹ 207.49 and ₹ 118.00 and for BSE is ₹ 207.40 and ₹ 118.25.

What is 1 year return for Kronox Lab Sciences Ltd?

Answer Field

The 1 year returns on the stock has been -26.41%.

What is the P/E Ratio of Kronox Lab Sciences Ltd Share?

Answer Field

As on Feb 16 2026 03:29 PM the price-to-earnings (PE) ratio for Kronox Lab Sciences Ltd share is 17.58.

What is the PB ratio of Kronox Lab Sciences Ltd Share?

Answer Field

As on Feb 16 2026 03:29 PM, the price-to-book (PB) ratio for Kronox Lab Sciences Ltd share is 27.32.

How to Buy Kronox Lab Sciences Ltd Share?

Answer Field

You can trade in Kronox Lab Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kronox Lab Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Kronox Lab Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kronox Lab Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59